BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

816 related articles for article (PubMed ID: 33478794)

  • 1. Immunoinformatics prediction of overlapping CD8
    Fatoba AJ; Maharaj L; Adeleke VT; Okpeku M; Adeniyi AA; Adeleke MA
    Vaccine; 2021 Feb; 39(7):1111-1121. PubMed ID: 33478794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID-19 coronavirus vaccine T cell epitope prediction analysis based on distributions of HLA class I loci (HLA-A, -B, -C) across global populations.
    Cun Y; Li C; Shi L; Sun M; Dai S; Sun L; Shi L; Yao Y
    Hum Vaccin Immunother; 2021 Apr; 17(4):1097-1108. PubMed ID: 33175614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring the out of sight antigens of SARS-CoV-2 to design a candidate multi-epitope vaccine by utilizing immunoinformatics approaches.
    Safavi A; Kefayat A; Mahdevar E; Abiri A; Ghahremani F
    Vaccine; 2020 Nov; 38(48):7612-7628. PubMed ID: 33082015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Revelation of Potent Epitopes Present in Unannotated ORF Antigens of SARS-CoV-2 for Epitope-Based Polyvalent Vaccine Design Using Immunoinformatics Approach.
    Uttamrao PP; Sathyaseelan C; Patro LPP; Rathinavelan T
    Front Immunol; 2021; 12():692937. PubMed ID: 34497604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Landscape and selection of vaccine epitopes in SARS-CoV-2.
    Smith CC; Olsen KS; Gentry KM; Sambade M; Beck W; Garness J; Entwistle S; Willis C; Vensko S; Woods A; Fini M; Carpenter B; Routh E; Kodysh J; O'Donnell T; Haber C; Heiss K; Stadler V; Garrison E; Sandor AM; Ting JPY; Weiss J; Krajewski K; Grant OC; Woods RJ; Heise M; Vincent BG; Rubinsteyn A
    Genome Med; 2021 Jun; 13(1):101. PubMed ID: 34127050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reverse vaccinology assisted designing of multiepitope-based subunit vaccine against SARS-CoV-2.
    Tahir Ul Qamar M; Shahid F; Aslam S; Ashfaq UA; Aslam S; Fatima I; Fareed MM; Zohaib A; Chen LL
    Infect Dis Poverty; 2020 Sep; 9(1):132. PubMed ID: 32938504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A vaccine built from potential immunogenic pieces derived from the SARS-CoV-2 spike glycoprotein: A computational approximation.
    Marchan J
    J Immunol Methods; 2022 Mar; 502():113216. PubMed ID: 35007561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immuno-informatics design of a multimeric epitope peptide based vaccine targeting SARS-CoV-2 spike glycoprotein.
    Chukwudozie OS; Gray CM; Fagbayi TA; Chukwuanukwu RC; Oyebanji VO; Bankole TT; Adewole RA; Daniel EM
    PLoS One; 2021; 16(3):e0248061. PubMed ID: 33730022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T and B cell Epitope analysis of SARS-CoV-2 S protein based on immunoinformatics and experimental research.
    Chen Z; Ruan P; Wang L; Nie X; Ma X; Tan Y
    J Cell Mol Med; 2021 Jan; 25(2):1274-1289. PubMed ID: 33325143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring the S Protein of SARS-CoV-2 to Design a Novel Multi-Epitope Vaccine against COVID-19 Based on Immunoinformatics Approaches.
    Huang Z; Shi H; Gong H; Sun Q; Yang S; Zhang Y; Shi Z; Xia Z; Huang S; Yao S; Xu F
    Front Biosci (Landmark Ed); 2024 May; 29(5):196. PubMed ID: 38812300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overlapping CD8+ and CD4+ T-cell epitopes identification for the progression of epitope-based peptide vaccine from nucleocapsid and glycoprotein of emerging Rift Valley fever virus using immunoinformatics approach.
    Adhikari UK; Rahman MM
    Infect Genet Evol; 2017 Dec; 56():75-91. PubMed ID: 29107145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An in silico deep learning approach to multi-epitope vaccine design: a SARS-CoV-2 case study.
    Yang Z; Bogdan P; Nazarian S
    Sci Rep; 2021 Feb; 11(1):3238. PubMed ID: 33547334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epitope-based peptide vaccines predicted against novel coronavirus disease caused by SARS-CoV-2.
    Lin L; Ting S; Yufei H; Wendong L; Yubo F; Jing Z
    Virus Res; 2020 Oct; 288():198082. PubMed ID: 32621841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel vaccine based on SARS-CoV-2 CD4
    Palatnik-de-Sousa I; Wallace ZS; Cavalcante SC; Ribeiro MPF; Silva JABM; Cavalcante RC; Scheuermann RH; Palatnik-de-Sousa CB
    Sci Rep; 2022 Oct; 12(1):16731. PubMed ID: 36202985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immuno-informatics approach for B-cell and T-cell epitope based peptide vaccine design against novel COVID-19 virus.
    Singh J; Malik D; Raina A
    Vaccine; 2021 Feb; 39(7):1087-1095. PubMed ID: 33478787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Proteome-Wide Immunoinformatics Tool to Accelerate T-Cell Epitope Discovery and Vaccine Design in the Context of Emerging Infectious Diseases: An Ethnicity-Oriented Approach.
    Oyarzun P; Kashyap M; Fica V; Salas-Burgos A; Gonzalez-Galarza FF; McCabe A; Jones AR; Middleton D; Kobe B
    Front Immunol; 2021; 12():598778. PubMed ID: 33717077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SARS-CoV-2 specific memory T cell epitopes identified in COVID-19-recovered subjects.
    Zhao J; Wang L; Schank M; Dang X; Lu Z; Cao D; Khanal S; Nguyen LN; Nguyen LNT; Zhang J; Zhang Y; Adkins JL; Baird EM; Wu XY; Ning S; Gazzar ME; Moorman JP; Yao ZQ
    Virus Res; 2021 Oct; 304():198508. PubMed ID: 34329696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preclinical evaluation of a synthetic peptide vaccine against SARS-CoV-2 inducing multiepitopic and cross-reactive humoral neutralizing and cellular CD4 and CD8 responses.
    Aparicio B; Casares N; Egea J; Ruiz M; Llopiz D; Maestro S; Olagüe C; González-Aseguinolaza G; Smerdou C; López-Díaz de Cerio A; Inogés S; Prósper F; Yuste JR; Carmona-Torre F; Reina G; Lasarte JJ; Sarobe P
    Emerg Microbes Infect; 2021 Dec; 10(1):1931-1946. PubMed ID: 34538222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunodominant linear B cell epitopes in the spike and membrane proteins of SARS-CoV-2 identified by immunoinformatics prediction and immunoassay.
    Polyiam K; Phoolcharoen W; Butkhot N; Srisaowakarn C; Thitithanyanont A; Auewarakul P; Hoonsuwan T; Ruengjitchatchawalya M; Mekvichitsaeng P; Roshorm YM
    Sci Rep; 2021 Oct; 11(1):20383. PubMed ID: 34650130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Excavating SARS-coronavirus 2 genome for epitope-based subunit vaccine synthesis using immunoinformatics approach.
    Chauhan V; Rungta T; Rawat M; Goyal K; Gupta Y; Singh MP
    J Cell Physiol; 2021 Feb; 236(2):1131-1147. PubMed ID: 32643158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.